When will Phase II endostatin trials begin?
Plans for Phase II clinical trials for endostatin are underway. These trials will help determine endostatin’s effectiveness. Data from the Phase I trials (for example, results on routes of administration, schedules of administration, and dosages) will be used to design the Phase II trials. These Phase II trials are expected to begin during the second quarter of this year. Phase II clinical trial sites have not yet been selected, and there are no “waiting lists” for patients at this time.
